IUHC:SW:SW-iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) USD (USD)

ETF | Others |

Last Closing

USD 10.86

Change

0.00 (0.00)%

Market Cap

USD 2.07B

Volume

4.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-103.00 (-1.45%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-60.00 (-1.24%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-23.00 (-1.53%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-25.50 (-1.26%)

USD 134,034.85B
SX7EEX:SW iShares EURO STOXX Banks 30-15..

-0.14 (-1.00%)

USD 6,289.31B
TDXPEX:SW iShares TecDAX® UCITS ETF (DE..

-0.28 (-0.93%)

USD 5,933.97B
SMIEX:SW iShares SLI UCITS ETF (DE)

-0.70 (-0.54%)

USD 5,933.96B
DJSXE:SW iShares Core EURO STOXX 50 UCI..

N/A

USD 5,933.96B
DAXEX:SW iShares Core DAX® UCITS ETF (..

-0.96 (-0.65%)

USD 5,933.93B
MDAXEX:SW iShares MDAX® UCITS ETF (DE) ..

+1.25 (+0.59%)

USD 5,933.92B

ETFs Containing IUHC:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.32% 39% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.32% 38% F 41% F
Trailing 12 Months  
Capital Gain 4.97% 47% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.97% 47% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.05% 55% F 55% F
Dividend Return 2.05% 55% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.87% 56% F 61% D-
Risk Adjusted Return 42.07% 50% F 54% F
Market Capitalization 2.07B 88% B+ 84% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike